CCL2 and Miyoshi myopathy: The cytokines of interest in this study—IL-6, IL-8, MCP-1, and VEGF—have been selected for their prominence in the MM microenvironment and their documented influence on disease progression and response to treatment, as well as their less understood roles in mediating chemotherapy-induced toxicity.